Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients

Journal of Hepatology

Volumn 59, Issue 6, 2013, Pages 1169-1176

  Petta, Salvatore ^a   Marchesini, Giulio ^b   Caracausi, Linda ^a   Macaluso, Fabio Salvatore ^a   Cammà, Calogero ^a   Ciminnisi, Stefania ^a   Cabibi, Daniela ^a   Porcasi, Rossana ^a   Craxì, Antonio ^a   Di Marco, Vito ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Chronic hepatitis C; Fructose; Liver fibrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; FRUCTOSE;

ADULT; ARTICLE; CLINICAL FEATURE; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FATTY LIVER; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; INSULIN RESISTANCE; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; STRUCTURED INTERVIEW; SUGAR INTAKE;

CHC; CHRONIC HEPATITIS C; DCL; DORSO-CERVICAL LIPOHYPERTROPHY; FRUCTOSE; G1; GENOTYPE 1; HCV; HEPATITIS C VIRUS; LIVER FIBROSIS; WAIST CIRCUMFERENCE; WAIST-TO-HIP RATIO; WC; WHR;

ADULT; AGED; FEMALE; FRUCTOSE; FRUIT; GENOTYPE; HEPATITIS C, CHRONIC; HUMANS; INDUSTRY; LIVER CIRRHOSIS; MALE; MIDDLE AGED;

EID: 84887996386     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.07.037     Document Type: Article

References (42)

1. K. Herzer, M.F. Sprinzl, and P.R. Galle Hepatitis viruses: live and let die Liver Int 27 2007 293 301
2. T. Poynard, M.F. Yuen, V. Ratziu, and C.L. Lai Viral Hepatitis C Lancet 362 2003 2095 2100
3. M. Romero-Gómez, M. Del Mar Viloria, R.J. Andrade, J. Salmerón, M. Diago, and C.M. Fernández-Rodríguez Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients Gastroenterology 128 2005 636 641
4. S. Petta, C. Cammà, V. Di Marco, D. Cabibi, S. Ciminnisi, and R. Caldarella Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection Antivir Ther 14 2009 631 639
5. E. Villa, A. Karampatou, C. Cammà, A. Di Leo, M. Luongo, and A. Ferrari Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C Gastroenterology 140 2011 818 829
6. S. Petta, D. Ferraro, C. Cammà, D. Cabibi, A. Di Cristina, and V. Di Marco Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C Antivir Ther 17 2012 823 831
7. S. Petta, C. Cammà, C. Scazzone, C. Tripodo, V. Di Marco, and A. Bono Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C Hepatology 51 2010 1158 1167
8. D.M. Torres, and S.A. Harrison Diagnosis and therapy of nonalcoholic steatohepatitis Gastroenterology 134 2008 1682 1698
9. L.H. Tetri, M. Basaranoglu, E.M. Brunt, L.M. Yerian, and B.A. Neuschwander-Tetri Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent Am J Physiol Gastrointest Liver Physiol 295 2008 G987 G995
10. I. Aeberli, M. Hochuli, P.A. Gerber, L. Sze, S.B. Murer, and L. Tappy Moderate amounts of fructose consumption impair insulin sensitivity in healthy young men: a randomized controlled trial Diabetes Care 2012 [Epub ahead of print]
11. J.C. de Ruyter, M.R. Olthof, J.C. Seidell, and M.B. Katan A trial of sugar-free or sugar-sweetened beverages and body weight in children N Engl J Med 367 2012 1397 1406
12. C.B. Ebbeling, H.A. Feldman, and V.R. Chomitz A randomized trial of sugar-sweetened beverages and adolescent body weight N Engl J Med 367 2012 1407 1416
13. Q. Qi, A.Y. Chu, and J.H. Kang Sugar-sweetened beverages and genetic risk of obesity N Engl J Med 367 2012 1387 1396
14. M.F. Abdelmalek, A. Suzuki, C. Guy, A. Unalp-Arida, R. Colvin, and R.J. Johnson Nonalcoholic Steatohepatitis Clinical Research Network. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease Hepatology 51 2010 1961 1971
15. G.L. Tyson, P.A. Richardson, D.L. White, J. Kuzniarek, D.J. Ramsey, and S. Tavakoli-Tabasi Dietary fructose intake and severity of liver disease in hepatitis C virus-infected patients J Clin Gastroenterol 2013 [Epub ahead of print] PubMed PMID: 23426443
16. American Diabetes Association Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. American Diabetes Association: Clinical Practice Recommendations 2000 Committee Report Diabetes Care 2000 2000 S4 S19
17. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
18. Y. Ikeda, T. Suehiro, T. Nakamura, Y. Kumon, and K. Hashimoto Clinical significance of the insulin resistance index as assessed by homeostasis model assessment Endocr J 48 2001 81 86
19. G. Colloredo, M. Guido, A. Sonzogni, and G. Leandro Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease J Hepatol 39 2003 239 244
20. P.J. Scheuer Classification of chronic viral hepatitis: a need for reassessment J Hepatol 13 1991 372 374
21. P. Bedossa, R. Moucari, E. Chelbi, T. Asselah, V. Paradis, and M. Vidaud Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study Hepatology 46 2 2007 Aug 380 387
22. F.E. Harrell Jr., K.L. Lee, and D.B. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387
23. J. Concato, A.R. Feinstein, and T.R. Holford The risk of determining risk with multivariable models Ann Intern Med 118 1993 201 210
24. SAS Technical Report, SAS/STAT software: changes and enhancement, Release 6.07. Cary, NC: SAS Institute, Inc.; 1992.
25. S. Zelber-Sagi, V. Ratziu, and R. Oren Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence World J Gastroenterol 17 2011 3377 3389
26. A.I. Cozma, J.L. Sievenpiper, R.J. de Souza, L. Chiavaroli, V. Ha, and D.D. Wang Effect of fructose on glycemic control in diabetes: a systematic review and meta-analysis of controlled feeding trials Diabetes Care 35 2012 1611 1620
27. D.D. Wang, J.L. Sievenpiper, R.J. de Souza, L. Chiavaroli, V. Ha, and A.I. Cozma The effects of fructose intake on serum uric acid vary among controlled dietary trials J Nutr 142 2012 916 923
28. J.L. Sievenpiper, L. Chiavaroli, R.J. de Souza, A. Mirrahimi, A.I. Cozma, and V. Ha 'Catalytic' doses of fructose may benefit glycaemic control without harming cardiometabolic risk factors: a small meta-analysis of randomised controlled feeding trials Br J Nutr 108 2012 418 423
29. J.L. Sievenpiper, R.J. de Souza, A. Mirrahimi, M.E. Yu, A.J. Carleton, and J. Beyene Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis Ann Intern Med 156 2012 291 304
30. V. Ha, J.L. Sievenpiper, R.J. de Souza, L. Chiavaroli, D.D. Wang, and A.I. Cozma Effect of fructose on blood pressure: a systematic review and meta-analysis of controlled feeding trials Hypertension 59 2012 787 795
31. J.L. Sievenpiper, A.J. Carleton, S. Chatha, H.Y. Jiang, R.J. de Souza, and J. Beyene Heterogeneous effects of fructose on blood lipids in individuals with type 2 diabetes: systematic review and meta-analysis of experimental trials in humans Diabetes Care 32 2009 1930 1937
32. L.G. Sánchez-Lozada, W. Mu, C. Roncal, Y.Y. Sautin, M. Abdelmalek, and S. Reungjui Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver Eur J Nutr 49 2010 1 9
33. Y. Nagai, S. Yonemitsu, D.M. Erion, T. Iwasaki, R. Stark, and D. Weismann The role of peroxisome proliferator activated receptor gamma coactivator-1 beta in the pathogenesis of fructose induced insulin resistance Cell Metab 9 2009 252 264
34. X. Ouyang, P. Cirillo, Y. Sautin, S. McCall, J.L. Bruchette, and A.M. Diehl Fructose consumption as a risk factor for non-alcoholic fatty liver disease J Hepatol 48 2008 993 999
35. M. Song, D.A. Schuschke, Z. Zhou, T. Chen, W.M. Pierce Jr., and R. Wang High fructose feeding induces copper deficiency in Sprague-Dawley rats: a novel mechanism for obesity related fatty liver J Hepatol 56 2012 433 440
36. I. Bergheim, S. Weber, M. Vos, S. Krämer, V. Volynets, and S. Kaserouni Antibiotics protect against fructoseinduced hepatic lipid accumulation in mice: role of endotoxin J Hepatol 48 2008 983 992
37. A. Spruss, G. Kanuri, S. Wagnerberger, S. Haub, S.C. Bischoff, and I. Bergheim Tolllike receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice Hepatology 50 2009 1094 1104
38. Y. Yilmaz Review article: fructose in non-alcoholic fatty liver disease Aliment Pharmacol Ther 35 2012 1135 1144
39. O. Cheung, A. Kapoor, P. Puri, S. Sistrun, V.A. Luketic, and C.C. Sargeant The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome Hepatology 46 2007 1091 1100
40. Y.J. Yang, M.K. Kim, S.H. Hwang, Y. Ahn, J.E. Shim, and D.H. Kim Relative validities of 3-day food records and the food frequency questionnaire Nutr Res Pract 4 2010 142 148
41. US Department of Agriculture. Economic Research Service. Sugar and Sweeteners Yearbook Tables. Available at: http://www.ers.usda.gov/topics/crops/ sugar-sweeteners.aspx [accessed 19.11.12].
42. C. Leclercq, D. Arcella, R. Piccinelli, S. Sette, C. Le Donne, and A. Turrini The Italian national food consumption survey INRAN.SCAI 2005-06: main results in terms of food consumption Public Health Nutr 12 2009 2504 2532